pBS L30 Flag-Apex-Rab7A
(Plasmid
#135652)
-
PurposeRab7A fused to APEX2 and a Flag tag in N-ter under control of a weak L30 promoter.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 135652 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBS
-
Modifications to backboneModified for mammalian expression using the promoter of the mouse ribosomal protein L30 gene ("weak promoter") and a HSV TK polyA tail
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameRab7A
-
Alt nameRab7
-
Alt nameras-related protein Rab-7a
-
SpeciesH. sapiens (human)
-
Insert Size (bp)624
-
GenBank IDNP_004628.4 7879
-
Entrez GeneRAB7A (a.k.a. CMT2B, PRO2706, RAB7)
- Promoter L30
-
Tags
/ Fusion Proteins
- FLag (N terminal on insert)
- Apex2 (N terminal on insert)
Cloning Information
- Cloning method Gateway Cloning
- 5′ sequencing primer M13pUC-fwd
- 3′ sequencing primer T3 (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pBS L30 Flag-Apex-Rab7A was a gift from Raphael Gaudin (Addgene plasmid # 135652 ; http://n2t.net/addgene:135652 ; RRID:Addgene_135652) -
For your References section:
Rab7-harboring vesicles are carriers of the transferrin receptor through the biosynthetic secretory pathway. Deffieu MS, Cesonyte I, Delalande F, Boncompain G, Dorobantu C, Song E, Lucansky V, Hirschler A, Cianferani S, Perez F, Carapito C, Gaudin R. Sci Adv. 2021 Jan 8;7(2). pii: 7/2/eaba7803. doi: 10.1126/sciadv.aba7803. Print 2021 Jan. 10.1126/sciadv.aba7803 PubMed 33523982